Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cyclin O is an atypical member of the cyclin protein family encoded by the CCNO gene. It is essential for the differentiation of multiciliated cells, where it functions downstream of key transcriptional regulators (like multicilin) to drive centriole amplification and the proper formation and function of deuterosomes. This process underlies the assembly of multiple motile cilia, which are critical for effective mucociliary clearance in respiratory epithelia and in other ciliated tissues. Loss-of-function mutations in CCNO impair centriole amplification and cilia formation, clinically manifesting as primary ciliary dyskinesia, reduced cilia generation, chronic lung disease, hydrocephalus, and infertility. Cyclin O is not generally considered a therapeutic target such as a receptor, enzyme, or transporter; instead, it is a cell cycle–regulating protein mainly implicated in developmental biology and disease pathogenesis through loss-of-function mutations[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclin O (CCNO).